SYNVANT
DEAD

Serial Number

97222990

Owner

SYNGENE INTERNATIONAL LIMITED

Attorney

Mark A. Watkins

Filing Date

Jan 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SYNVANT Trademark

Serial Number: 97222990

SYNVANT is a trademark filed by SYNGENE INTERNATIONAL LIMITED on January 17, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SYNGENE INTERNATIONAL LIMITED (13 trademarks)

Biocon Special Economic Zone,Biocon Park
Link Rd, Bangalore Karnataka , IN

Entity Type: 03

Trademark Details

Filing Date

January 17, 2022

Registration Date

Not Registered

Published for Opposition

April 25, 2023

Goods & Services

Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes pharmaceutical preparations for the treatment of diseases and conditions in the fields of oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; biopharmaceuticals for the treatment of cancer; protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical diagnostic use; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma, diabetes, multiple sclerosis, acne; chemical preparations for use in DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes

Paper and cardboard; printed matter, namely, catalogs and brochures in the field of biotechnology; Bookbinding materials for creating hardcover books, namely, book covers, crackand-peel binding paper, reinforcement strips, peel-and-stick labels, stapler and staples; printed photographs; Plastic sheets, films and bags for wrapping and packaging; Plastic film for packaging; paper tags; paper bags for packaging; printed business cards; Bags of paper or plastics for packaging; printed vouchers

Maintaining patient medical records and files; Advertising research; Business research services; Market analysis and research services; Compilation of statistical data relating to medical research; Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare

Biotechnological products and preparations for laboratory use, namely, enzymes, proteins, carbohydrates, lipids, nucleic acids, DNA, immunological re-agents, and organic intermediates being fine chemicals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne, meningitis, asthma; chemicals for industrial use; assays for research purposes; unprocessed chemical polymers; chemicals for use in biotechnological product development; cells for scientific, laboratory or medical research; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; proteins for use in recombinant DNA technology for laboratory use; chemicals being reference standards for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific research; assays for research purposes(duplicate entry); diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; none of the aforesaid goods relating to gel imaging and gel analysis applications and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes

Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; pathology services for medical and medical diagnostic purposes; medical testing services

Pharmaceutical research and development; medical and scientific research services in the field of cancer treatment and diagnosis, cardiology, nephrology, endocrinology; chemical, biochemical, biological and bacteriological research and analysis; Research and development in the field of diagnostic preparations; Biomedical research services; Computer aided scientific research, testing and analysis services; in the fields of medicine and pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Scientific research and custom design of pharmaceuticals; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; research and development services in the field of antibodies, antibody technology; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; DNA analysis services for scientific research purposes; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; scientific and medical laboratory services; services of a chemical and biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 22, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 22, 2024 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 22, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 22, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 22, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 22, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 12, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 12, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 12, 2022 CNRT
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 1, 2022 GPRN
PRIORITY ACTION E-MAILED
Nov 1, 2022 GPRA
PRIORITY ACTION WRITTEN
Nov 1, 2022 CPRA
ASSIGNED TO EXAMINER
Oct 25, 2022 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jan 25, 2022 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 25, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2022 NWOS
NEW APPLICATION ENTERED
Jan 20, 2022 NWAP